However, a statistically significant increase was observed only for CA-125 at all stages of breast cancer (Figure 2A), CYFRA 21-1 at advanced stages (Figure 2B), and CA 19-9 at stage II breast cancer (Figure 2C). Here, MUC16 is linked to breast carcinoma.